Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1520-2025

Tandem Mobi Insulin Pump with Interoperable Technology Recall

Tandem Mobi Insulin Pump with Interoperable Technology

FDA recall Class I

Ongoing

FDA lists this Class I recall for Tandem Mobi Insulin Pump with Interoperable Technology. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1520-2025
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Feb 27, 2025
FDA report date
Apr 23, 2025
Quantity in commerce
85 units
Distribution
See key details
FDA cause
Software Design Change

What is being recalled?

Tandem Mobi Insulin Pump with Interoperable Technology

Affected model & UDI checker

Search the exact identifiers published for Z-1520-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedTandem Mobi Insulin Pump with Interoperable TechnologyCheck source notice00389152480114
FDA code information

Software versions 7.9/UDI: 00389152480114

View the original FDA recall notice

Why was this product recalled?

A software defect in Version 7.9 of the pump software for Tandem t:slim X2 and Tandem Mobi pumps, when used with Control IQ+ technology, will cause the pump to incorrectly interpolate glucose trends when the Estimated Glucose Value (EGV) is above 255 mg/dL at the start or end of a gap in data collection due to a lapse in connection from a paired continuous glucose monitor (CGM) sensor, which can lead to under-delivery or over-delivery of insulin based on inaccurate result leading to severe cases of hypoglycemia or hyperglycemia.

What actions did Tandem Diabetes Care, Inc. take?

On February 28, 2025 Tandem Diabetes Care contacted each affected customer by phone concerning a Urgent Medical Device Correction. On March 11, 2025, Tandem followed up with a "Urgent Medical Device" Recall notification via E-Mail to affected consignees. Tandem ask consignees to take the following action: 1. Turn off Control-IQ+ immediately. You may continue to use your pump without Control-IQ active. Your pump will deliver insulin based on your programmed active personal profile and will not automatically adjust insulin delivery. 2. Please refer to the user guide provided with your pump for more detailed instructions. 3. Continue using your Tandem pump as described in the User Guide. 4. Pay attention to all system alerts and alarms. 5. Always carry back-up supplies.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology